<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A many <z:hpo ids='HP_0000708'>behavioral disturbances</z:hpo>, <z:hpo ids='HP_0000733'>Stereotypic behaviors</z:hpo> are among the best discriminators of <z:e sem="disease" ids="C0751072" disease_type="Mental or Behavioral Dysfunction" abbrv="FTLD">Frontotemporal Lobar Degeneration</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>A recent preliminary report suggests many of the behavioral symptoms, including <z:hpo ids='HP_0000733'>stereotypic behaviors</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e> patients, respond to medication with selective <z:chebi fb="19" ids="28790">serotonin</z:chebi> re-uptake inhibitors </plain></SENT>
<SENT sid="2" pm="."><plain>However, there is no scale that evaluates <z:hpo ids='HP_0000733'>stereotypic behaviors</z:hpo> comprehensively </plain></SENT>
<SENT sid="3" pm="."><plain>To assess the wide range of <z:hpo ids='HP_0000733'>stereotypic behaviors</z:hpo> encountered in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e>, we developed a new instrument, the <z:hpo ids='HP_0000733'>Stereotypy</z:hpo> Rating Inventory (SRI) </plain></SENT>
<SENT sid="4" pm="."><plain>The SRI assesses five distinctive stereotypic <z:hpo ids='HP_0000708'>behavioral disturbances</z:hpo> often seen in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e>: eating and cooking behaviors, roaming, speaking, movements, and daily rhythm </plain></SENT>
<SENT sid="5" pm="."><plain>The SRI uses the same technique as the Neuropsychiatric Inventory (NPI) in that both the frequency and the severity of each behavior are determined </plain></SENT>
<SENT sid="6" pm="."><plain>The studies reported here demonstrate the content and concurrent validity, as well as inter-rater and test-retest reliability, of the instrument </plain></SENT>
<SENT sid="7" pm="."><plain>Scores of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e> patients (n=26) on the SRI were much higher than those of patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (n=46), patients with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (n=26), and <z:mpath ids='MPATH_458'>normal</z:mpath> control subjects (n=40) </plain></SENT>
<SENT sid="8" pm="."><plain>The SRI appears to be a useful instrument for detecting <z:hpo ids='HP_0000733'>stereotypic behaviors</z:hpo> and monitoring of therapies in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e> patients </plain></SENT>
</text></document>